Alberta Investment Management Corp Ionis Pharmaceuticals Inc Transaction History

Alberta Investment Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $3.76 Million - $4.72 Million	101,426 New	101,426 $3.83 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $2.33 Million - $3.58 Million	-44,100 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $1.91 Million - $2.63 Million	44,100 New	44,100 $2.38 Million
Q3 2018 Nov 16, 2018	SELL	$42.88 - $53.7 $510,272 - $639,030	-11,900 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$40.53 - $50.7 $482,307 - $603,330	11,900 New	11,900 $496,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.